Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 125, Issue 2, 2001, Pages 87-99

  Luk, Catherine ^a   Tsao, M S ^a,b,c   Bayani, Jane ^a,c   Shepherd, F ^b,c   Squire, Jeremy A ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 8Q; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOLOGY; HUMAN; HUMAN CELL; KARYOTYPING; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; SPECTRAL KARYOTYPING;

ADENOCARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; DNA, NEOPLASM; GENE AMPLIFICATION; GENES, MYC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LUNG NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; TUMOR CELLS, CULTURED;

EID: 0035026584     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00363-0     Document Type: Article

References (56)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1998. CA Cancer J Clin. 48:1998;6-29. [published errata appear in CA Cancer J Clin 1998;48(3):192 and 1998 Nov-Dec;48(6):329].
2. Lukeis R., Irving L., Garson M., Hasthorpe S. Cytogenetics of non-small cell lung cancer. analysis of consistent non-random abnormalities Genes Chromosomes Cancer. 2:1990;116-124.
3. Miura I., Siegfried J.M., Resau J., Keller S.M., Zhou J.Y., Testa J.R. Chromosome alterations in 21 non-small cell lung carcinomas. Genes Chromosomes Cancer. 2:1990;328-338.
4. Testa J.R., Siegfried J.M., Liu Z., Hunt J.D., Feder M.M., Litwin S., Zhou J.Y., Taguchi T., Keller S.M. Cytogenetic analysis of 63 non-small cell lung carcinomas. recurrent chromosome alterations amid frequent and widespread genomic upheaval Genes Chromosomes Cancer. 11:1994;178-194.
5. Johansson M., Jin Y., Mandahl N., Hambraeus G., Johansson L., Mitelman F., Heim S. Cytogenetic analysis of short-term cultured squamous cell carcinomas of the lung. Cancer Genet Cytogenet. 81:1995;46-55.
6. Berker-Karauzum S., Luleci G., Ozbilim G., Erdogan A., Kuzucu A., Demircan A. Cytogenetic findings in thirty lung carcinoma patients. Cancer Genet Cytogenet. 100:1998;114-123.
7. Sato S., Nakamura Y., Tsuchiya E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 54:1994;5652-5655.
8. Shiseki M., Kohno T., Nishikawa R., Sameshima Y., Mizoguchi H., Yokota J. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res. 54:1994;5643-5648.
9. Wiest J.S., Franklin W.A., Otstot J.T., Forbey K., Varella-Garcia M., Rao K., Drabkin H., Gemmill R., Ahrent S., Sidransky D., Saccomanno G., Fountain J.W., Anderson M.W. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung. the location of a putative tumor suppressor gene Cancer Res. 57:1997;1-6.
10. Fong K.M., Zimmerman P.V., Smith P.J. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer. Genes Chromosomes Cancer. 10:1994;183-189.
11. Fong K.M., Zimmerman P.V., Smith P.J. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res. 55:1995;220-223.
12. Fong K.M., Kida Y., Zimmerman P.V., Ikenaga M., Smith P.J. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res. 55:1995;4268-4272.
13. Mitsudomi T., Oyama T., Nishida K., Ogami A., Osaki T., Sugio K., Yasumoto K., Sugimachi K., Gazdar A.F. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication. Clin Cancer Res. 2:1996;1185-1189.
14. Fleischman E.W., Reshmi S., Sokova O.I., Kirichenko O.P., Konstantinova L.N., Kulagina O.E., Frenkel M.A., Rowley J.D. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet. 108:1999;166-170.
15. Haddad B.R., Schrock E., Meck J., Cowan J., Young H., Ferguson-Smith M.A., du Manoir S., Ried T. Identification of de novo chromosomal markers and derivatives by spectral karyotyping. Hum Genet. 103:1998;619-625.
16. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
17. Pandita A., Zielenska M., Thorner P., Bayani J., Greenberg M., Godbout R., Squire J. Application of comaparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia. 1:1999;262-275.
18. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., Ried T. Multicolor spectral karyotyping of human chromosomes. Science. 273:1996;494-497. [see comments].
19. Taguchi T., Zhou J.Y., Feder M., Litwin S., Klein-Szanto A.J., Testa J.R. Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes. Cancer Genet Cytogenet. 89:1996;120-125.
20. Okami K., Cairns P., Westra W.H., Linn J.F., Ahrendt S.A., Wu L., Sidransky D., Jen J. Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization. Int J Cancer. 74:1997;588-592.
21. Balsara B.R., Sonoda G., du Manoir S., Siegfried J.M., Gabrielson E., Testa J.R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res. 57:1997;2116-2120.
22. Bjorkqvist A.M., Husgafvel-Pursiainen K., Anttila S., Karjalainen A., Tammilehto L., Mattson K., Vainio H., Knuutila S. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer. 22:1998;79-82.
23. Petersen I., Bujard M., Petersen S., Wolf G., Goeze A., Schwendel A., Langreck H., Gellert K., Reichel M., Just K., du Manoir S., Cremer T., Dietel M., Ried T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 57:1997;2331-2335.
24. Bjorkqvist A.M., Tammilehto L., Nordling S., Nurminen M., Anttila S., Mattson K., Knuutila S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer. 77:1998;260-269.
25. Speicher M.R., Petersen S., Uhrig S., Jentsch I., Fauth C., Eils R., Petersen I. Analysis of chromosomal alterations in non-small cell lung cancer by multiplex-FISH, comparative genomic hybridization, and multicolor bar coding. Lab Invest. 80:2000;1031-1041.
26. Liu C., Tsao M.S. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines. Am J Pathol. 142:1993;413-423.
27. Verma R.S., Babu A. Human chromosomes. 1995;McGraw-Hill Inc, New York.
28. Dracopoli N.C. Current protocols in human genetics. 1999;John Wiley & Sons Inc, New York.
29. du Manoir S., Schrock E., Bentz M., Speicher M.R., Joos S., Ried T., Lichter P., Cremer T. Quantitative analysis of comparative genomic hybridization. Cytometry. 19:1995;27-41.
30. Lundsteen C., Maahr J., Christensen B., Bryndorf T., Bentz M., Lichter P., Gerdes T. Image analysis in comparative genomic hybridization. Cytometry. 19:1995;42-50.
31. Piper J., Rutovitz D., Sudar D., Kallioniemi A., Kallioniemi O.P., Waldman F.M., Gray J.W., Pinkel D. Computer image analysis of comparative genomic hybridization. Cytometry. 19:1995;10-26.
32. Heselmeyer K., Schrock E., du Manoir S., Blegen H., Shah K., Steinbeck R., Auer G., Ried T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA. 93:1996;479-484.
33. Ried T., Petersen I., Holtgreve-Grez H., Speicher M.R., Schrock E., du Manoir S., Cremer T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54:1994;1801-1806.
34. Speicher M.R., Howe C., Crotty P., du Manoir S., Costa J., Ward D.C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 55:1995;1010-1013.
35. Larramendy M.L., Tarkkanen M., Blomqvist C., Virolainen M., Wiklund T., Asko-Seljavaara S., Elomaa I., Knuutila S. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol. 151:1997;1153-1161.
36. Tarkkanen M., Elomaa I., Blomqvist C., Kivioja A.H., Kellokumpu-Lehtinen P., Bohling T., Valle J., Knuutila S. DNA sequence copy number increase at 8q. a potential new prognostic marker in high-grade osteosarcoma Int J Cancer. 84:1999;114-121.
37. Brass N., Racz A., Heckel D., Remberger K., Sybrecht G.W., Meese E.U. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res. 57:1997;2290-2294.
38. Zhang H., Kobayashi R., Galaktionov K., Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 82:1995;915-925.
39. Anagnou N.P., Economou-Pachnis A., O'Brien S.J., Modi W.S., Nienhuis A.W., Tsichlis P.N. The human homolog of the Moloney leukemia virus integration 2 locus (MLV12) maps to band p14 of chromosome 5. Genomics. 5:1989;354-358.
40. Johnson B. The role of MYC. JUN. and FOS oncogenes in human lung cancer: principles and practice. Pass HL, et al., editors. Philadelphia: Lippincott-Raven, 1996. p. 83-98.
41. Volm M., Efferth T., Mattern J. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res. 12:1992;11-20.
42. Fearon E.R., Cho K.R., Nigro J.M., Kern S.E., Simons J.W., Ruppert J.M., Hamilton S.R., Preisinger A.C., Thomas G., Kinzler K.W.et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 247:1990;49-56.
43. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., da Costa L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., Kern S.E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271:1996;350-353. [see comments].
44. Petersen S., Aninat-Meyer M., Schluns K., Gellert K., Dietel M., Petersen I. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer. 82:2000;65-73.
45. Nagatake M., Takagi Y., Osada H., Uchida K., Mitsudomi T., Saji S., Shimokata K., Takahashi T. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 56:1996;2718-2720.
46. Lu Y.J., Dong X.Y., Shipley J., Zhang R.G., Cheng S.J. Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma. Lung Cancer. 23:1999;61-66.
47. Dennis T.R., Stock A.D. A molecular cytogenetic study of chromosome 3 rearrangements in small cell lung cancer. consistent involvement of chromosome band 3q13.2 Cancer Genet Cytogenet. 113:1999;134-140.
48. Michelland S., Gazzeri S., Brambilla E., Robert-Nicoud M. Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas. Cancer Genet Cytogenet. 114:1999;22-30.
49. Knuutila S., Bjorkqvist A.M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.M., Vidgren V., Zhu Y. DNA copy number amplifications in human neoplasms. review of comparative genomic hybridization studies Am J Pathol. 152:1998;1107-1123.
50. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers.Nature. 396:1998;643-649.
51. Gasperi-Campani A., Roncuzzi L., Ricotti L., Lenzi L., Gruppioni R., Sensi A., Zini N., Zoli W., Amadori D. Molecular and biological features of two new human squamous and adenocarcinoma of the lung cell lines. Cancer Genet Cytogenet. 107:1998;11-20.
52. Zhou J.Y., Taguchi T., Siegfried J.M., Jhanwar S.C., Resau J., Testa J.R. Characterization of 9q;15q whole-arm translocation derivatives in non-small cell lung carcinomas by fluorescence in situ hybridization. Cancer Genet Cytogenet. 69:1993;1-6.
53. Wick W., Petersen I., Schmutzler R.K., Wolfarth B., Lenartz D., Bierhoff E., Hummerich J., Muller D.J., Stangl A.P., Schramm J., Wiestler O.D., von Deimling A. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene. 12:1996;973-978.
54. Speicher M.R., Gwyn Ballard S., Ward D.C. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet. 12:1996;368-375.
55. Geradts J., Fong K.M., Zimmerman P.V., Minna J.D. Loss of Fhit expression in non-small-cell lung cancer. correlation with molecular genetic abnormalities and clinicopathological features Br J Cancer. 82:2000;1191-1197.
56. Tseng J.E., Kemp B.L., Khuri F.R., Kurie J.M., Lee J.S., Zhou X., Liu D., Hong W.K., Mao L. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res. 59:1999;4798-4803.